Crohn's disease patients soon may have two new treatments; the FDA has approved Tysabri and the manufacturer for Cimzia plans to seek approval soon. "It's much better to get Crohn's disease in 2007 than 1987. I think the future looks very different for these groups of patients," one gastroenterologist said.

Related Summaries